Medicines Company (The)
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 687,864 558,588 484,732 437,645
Cost of Revenue 262,785 177,339 156,866 129,299
Gross Profit 425,079 381,249 327,866 308,346
Operating Expenses
Research and Development 146,930 126,423 110,180 85,241
Sales, General and Admin. 264,958 171,753 159,617 158,690
Non-Recurring Items - - - -
Other - - - -
Operating Income 13,191 83,073 58,069 64,415
Income From Continuing Operations
Add'l Income/Expense Items 18,960 11,140 19,774 (267)
Earnings Before Interest and Tax 32,151 94,213 77,843 64,148
Interest Expense 15,531 8,005 - -
Earnings Before Tax 16,620 86,208 77,843 64,148
Income Tax 1,360 35,038 (50,034) (40,487)
Minority Interest (252) (84) - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 15,512 51,254 127,877 104,635
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 15,512 51,254 127,877 104,635
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 15,512 51,254 127,877 104,635